Insider trades
Reardon Andrew
Reardon Andrew made 0 buys and 62 sales on the open market in the last 12 months at Ligand Pharmaceuticals Incorporated. Each trade with the role, price and filing.
| Date | Company | Trade | Shares | Price |
|---|---|---|---|---|
| Nov 2, 2026 | Ligand Pharmaceuticals Incorporated | Sale | 708 | US$308.43 |
| Nov 2, 2026 | Ligand Pharmaceuticals Incorporated | Sale | 522 | US$309.91 |
| Nov 2, 2026 | Ligand Pharmaceuticals Incorporated | Sale | 490 | US$310.61 |
| Nov 2, 2026 | Ligand Pharmaceuticals Incorporated | Sale | 520 | US$311.72 |
| Nov 2, 2026 | Ligand Pharmaceuticals Incorporated | Sale | 634 | US$312.85 |
| Nov 2, 2026 | Ligand Pharmaceuticals Incorporated | Sale | 403 | US$313.75 |
| Nov 2, 2026 | Ligand Pharmaceuticals Incorporated | Sale | 80 | US$314.58 |
| Nov 2, 2026 | Ligand Pharmaceuticals Incorporated | Sale | 280 | US$317.91 |
| Nov 2, 2026 | Ligand Pharmaceuticals Incorporated | Sale | 440 | US$318.73 |
| Nov 2, 2026 | Ligand Pharmaceuticals Incorporated | Sale | 320 | US$319.97 |